Rockwell Medical (RMTI) Tops Q2 EPS by 9c, provides guidance
Tweet
Share
E-mailGet Alerts RMTI Hot Sheet
Price: $5.61 -2.6%
EPS Growth %: -200.0%
Financial Fact:
Income Tax Expense: 0
Today's EPS Names:
CCEL, FEIM, PLG, More
EPS Growth %: -200.0%
Financial Fact:
Income Tax Expense: 0
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
Rockwell Medical (NASDAQ: RMTI) reported Q2 EPS of $0.05, $0.09 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $25.83 million versus the consensus estimate of $22.91 million.
GUIDANCE:
Rockwell Medical sees FY2024 revenue of $95-98 million, versus the consensus of $92.493 million.
Adjusted EBITDA: $0.75 to $1.5 million.
For earnings history and earnings-related data on Rockwell Medical (RMTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Occidental Petroleum releases Q2 2026 earnings considerations
- Faraday Future registers up to 62M shares for resale
- GuideAI Health hires firms for marketing and investor outreach
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
